Ansari Mohd Nazam, Rehman Najeeb Ur, Karim Aman, Soliman Gamal A, Ganaie Majid A, Raish Mohammad, Hamad Abubaker M
Department of Pharmacology and Toxicology, College of Pharmacy, Prince Sattam Bin Abdulaziz University, Al-Kharj 11942, Saudi Arabia.
Department of Biological Sciences, National University of Medical Sciences, Rawalpindi 46000, Pakistan.
Life (Basel). 2021 Mar 3;11(3):195. doi: 10.3390/life11030195.
Ulcerative colitis (UC) is an inflammatory bowel disease (IBD) that causes irritation, inflammation, and ulceration in the linings of the colon and rectum. is traditionally used to treat various disorders in different parts of the Middle East and sub-Saharan Africa. In the present study, we evaluated the ameliorative effects of crude leaves extract of (OF.Cr) on acetic acid (AA)-induced UC model in Wistar albino rats. Wistar rats were administered orally with either vehicle (10 mL/kg), OF.Cr (200 and 400 mg/kg), or prednisolone (2 mg/kg) once a day for 6 days. On day 6, UC was induced in rats by intrarectal administration of a single dose of 5% AA (1.0 mL). Disease activity index (DAI) was recorded after one day of colitis induction by assessing the symptoms of colitis and then the rats were euthanized by cervical dislocation, and colon tissues were isolated for the histopathological examination and biochemical analysis of oxidative stress parameters and cytokines (Interleukin-6 and Tumor Necrosis Factor-α). OF.Cr pretreatment exhibits significant prevention against UC, as confirmed by a significant decrease of DAI, colonic ulceration, and reduced inflammatory score as compared to the AA-induced colitis rats. Depletion of total glutathione (GSH) levels and catalase (CAT) activities in the colitis group was significantly restored in the OF.Cr treated groups, while increased lipid peroxidation in the colon tissues was significantly reduced. OF.Cr prevented the activation of the IL-6 and TNF-α pathways in the colonic tissues, which were clearly observed by the decreased levels of IL-6 and TNF-α in the OF.Cr treated animals. Hence, OF.Cr could be developed in the future for the treatment of UC.
溃疡性结肠炎(UC)是一种炎症性肠病(IBD),可导致结肠和直肠内壁出现刺激、炎症和溃疡。传统上用于治疗中东和撒哈拉以南非洲不同地区的各种疾病。在本研究中,我们评估了[植物名称]粗叶提取物(OF.Cr)对Wistar白化大鼠乙酸(AA)诱导的UC模型的改善作用。Wistar大鼠每天口服给予赋形剂(10 mL/kg)、OF.Cr(200和400 mg/kg)或泼尼松龙(2 mg/kg),连续6天。在第6天,通过直肠内给予单剂量5% AA(1.0 mL)诱导大鼠发生UC。在诱导结肠炎1天后,通过评估结肠炎症状记录疾病活动指数(DAI),然后通过颈椎脱臼对大鼠实施安乐死,并分离结肠组织进行组织病理学检查以及氧化应激参数和细胞因子(白细胞介素-6和肿瘤坏死因子-α)的生化分析。与AA诱导的结肠炎大鼠相比,OF.Cr预处理对UC表现出显著的预防作用,DAI、结肠溃疡显著降低,炎症评分降低得到证实。在OF.Cr处理组中,结肠炎组总谷胱甘肽(GSH)水平和过氧化氢酶(CAT)活性的消耗得到显著恢复,而结肠组织中脂质过氧化增加显著降低。OF.Cr阻止了结肠组织中IL-6和TNF-α途径的激活,这在OF.Cr处理动物中通过IL-6和TNF-α水平降低明显观察到。因此,OF.Cr未来可开发用于治疗UC。